Medical technologies and healthcare solutions distributor Designs For Vision, part of ParagonCare, has announced the imminent launch of PM1 Pachymeter from Occuity in Australia and New Zealand.
It’s being described as a “groundbreaking” handheld, non-contact device that enables swift and accurate measurement of central corneal thickness in seconds.
Unlike traditional handheld ultrasound devices, the company said the PM1 required no consumables and offered “an unparalleled patient and practitioner experience”. It eliminates the need for multiple contacts with the cornea, a significant advancement in ophthalmic diagnostics.
Ms Franziska Klatt, strategic marketing manager, said ParagonCare was thrilled to bring Occuity’s innovative handheld non-contact optical instruments to Australia and New Zealand.
“The PM1 and future devices from Occuity are providing clear advantages for patients and users compared to existing solutions, and we look forward to working with them,” she said.
Mr Mark Jenkins, chief operating officer at Occuity added: “We are delighted to work with Designs For Vision, a company with a trusted reputation in supplying world-leading diagnostic and surgical eyecare solutions.
“Australia and New Zealand are territories that often lead the way in eyecare and the adoption of new technology, so this launch is an important milestone for Occuity. Designs for Vision’s dedication to sourcing and promoting the best quality products, makes them the perfect partner for Occuity’s innovative products.
“We look forward to working with them to introduce the PM1 and Occuity’s future devices, such as the AX1 Axiometer, to a wide audience across the Australasia region.”
The PM1 Pachymeter is awaiting TGA certification ahead of a market launch in 2024. For more information, visit here or contact ParagonCare and Designs For Vision via marketing@dfv.com.au.
More reading
OCULUS Myopia Master: ‘A myopia clinic straight out of the box’
Save Sight, KA brochure explains CXL for keratoconus patients
Keratoconus: A frank discussion with Dr Abi Tenen
